BERKLEY W R CORP - EUCRATES BIOMEDICAL ACQU COR ownership

Back to all holdings Add to watchlist

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 38 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
BERKLEY W R CORP ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q3 2022$1,193,000
+1.4%
119,0470.0%0.06%0.0%
Q2 2022$1,177,000
+0.5%
119,0470.0%0.06%
-3.3%
Q1 2022$1,171,000
+201.0%
119,047
+198.4%
0.06%
+185.7%
Q4 2021$389,000–39,898–0.02%–
 Download
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q2 2022
NameSharesValueWeighting ↓
SkyView Investment Advisors, LLC 71,773$7170.22%
EcoR1 Capital, LLC 200,000$1,998,0000.06%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 3,483$34,7950.00%
Tower Research Capital LLC (TRC) 657$70.00%
DEUTSCHE BANK AG\ 21,923$219,0110.00%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders